Complementary and antagonistic effects of combined glucagon‐like peptide‐2 and glucagon‐like peptide‐1 receptor agonist administration on parameters relevant to short bowel syndrome

2021 ◽  
Author(s):  
Arjuna Srikrishnaraj ◽  
Hyerin Jeong ◽  
Patricia L. Brubaker
Keyword(s):  
Short Bowel Syndrome ◽  
Receptor Agonist ◽  
Antagonistic Effects ◽  
Short Bowel ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Experience of the Glucagon-like Peptide-1 (GLP-1) Agonist for the Treatment of Short Bowel Syndrome

2012 ◽  
Vol 2 (1) ◽  
pp. 11-13
Author(s):  
Jia Ryu ◽  
Jiyoung Jang ◽  
Hongjin Shim ◽  
Huyngwon Kim ◽  
Jae Gil Lee
Keyword(s):  
Short Bowel Syndrome ◽  
Short Bowel ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome

2011 ◽  
Vol 23 (8) ◽  
pp. 739-e328 ◽  
Author(s):  
D. Kunkel ◽  
B. Basseri ◽  
K. Low ◽  
S. Lezcano ◽  
E. E. Soffer ◽  
...  
Keyword(s):  
Short Bowel Syndrome ◽  
Short Bowel ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Dulaglutide, a glucagon-like peptide-1 receptor agonist: in the search for survival molecule

2020 ◽  
Vol 9 (2) ◽  
pp. 49-58
Author(s):  
A.S. Ametov ◽  
◽  
A.O. Nevolnikova ◽  
E.A. Tertychnaya ◽  
O.A. Mishra ◽  
...  
Keyword(s):  
Receptor Agonist ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice

2014 ◽  
Author(s):  
Marie Pereira ◽  
Jeshmi Jeyabalan ◽  
Camilla Sofie Jorgensen ◽  
Mark Cleasby ◽  
Mark Hopkinson ◽  
...  
Keyword(s):  
Bone Mass ◽  
Receptor Agonist ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Use of Big-Data Algorithms to Characterize Patients with T2D on Basal Insulin (BI) Who Add a Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) and Predict Their A1C Response

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 100-LB ◽  
Author(s):  
ESTHER ZIMMERMANN ◽  
ADAM LENART ◽  
JOAO DIOGO DA ROCHA FERNANDES ◽  
SARAH EGGERT ◽  
MATTIS F. RANTHE
Keyword(s):  
Big Data ◽  
Basal Insulin ◽  
Receptor Agonist ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Attenuates Prostate Cancer Cell Proliferation via Phosphorylation of MKP-1

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1957-P
Author(s):  
TAKAKO KAWANAMI ◽  
TAKASHI NOMIYAMA ◽  
YURIKO HAMAGUCHI ◽  
TOMOKO TANAKA ◽  
TOSHIHIKO YANASE
Keyword(s):  
Prostate Cancer ◽  
Cell Proliferation ◽  
Cancer Cell ◽  
Receptor Agonist ◽  
Prostate Cancer Cell ◽  
Cancer Cell Proliferation ◽  
Glucagon Like Peptide ◽  
Glucagon Like Peptide 1
Sign in / Sign up

Export Citation Format

Share Document